Last modified
05/26/2018 - 09:02


Product Description

CAS Number : 184475-35-2
Molecular Formula :C22H24ClFN4O3
Formula Weight : 446.9g/mol
Specification :
Formulation:A crystalline solid
Stability:2 years
Description :
Overactivity of the epidermal growth factor receptor-associated tyrosine kinase (EGFR-TK) has been associated with a number of cancers and thus TK inhibitors could be potential therapeutic agents to prevent malignant growth.1 Iressa is a selective EGFR-TK inhibitor that blocks the growth of GEO colon cancer, ZR-75-1 and MCF-10A Ha-ras breast cancer, and OVCAR-3 ovarian cancer cell lines with IC50s ranging between 0.2 - 0.4 µM.2 By interfering with the intracellular kinase domain, iressa prevents EGFR autophosphorylation and prevents downstream signal transduction. Iressa has been used to treat advanced (or recurrent) non-small cell lung cancer (NSCLC). However, the FDA retracted its general approval for this compound when a phase III trial failed to demonstrate an overall survival benefit.3 Iressa appears to be most efficacious in treating certain EGFR gene mutations that are prevalent in Asian populations.4,5 
Storage : -20°C

Send inquiry online For more product information and prices

(Pharmaceutical Ingredients Manufacturer & Supplier & Exporter.)

After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email. —— Green Stone Swiss

Email: [email protected]
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Send inquiry online: